Corbus Pharmaceuticals Holdings Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc. | Cash Flow

No data

About Corbus Pharmaceuticals Holdings

View Profile

Address	500 River Ridge Drive Norwood Massachusetts 02062 United States
Employees	-
Website	http://www.corbuspharma.com
Updated	07/08/2019
Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.